Individuals and their families no longer need to be passive about their health in the face of these risks - the Asia Genomics and CellMax Life partnership will give everyone more control over their health. This an indication that cancer is not diagnosed until later stages in Asia, when it becomes difficult to treat effectively.
Only in Africa were cancer patients more likely to die (0.73). The advanced diagnostic testing will reduce cancer mortality through personalized, precision cancer risk assessment and screening in the Philippines, Vietnam, Malaysia, Thailand, and Singapore.Īffordable Precision Testing Gives Individuals Achieve More Control According to the GLOBOCAN database, the ratio of cancer deaths to the number of new cancer cases in Asia was 0.66, twice that of North America (0.33). CellMax and Asia Genomics Enter Broad Partnership to Serve South-East Asia Singapore and Sunnyvale, CA, JAsia Genomics, Southeast Asia’s leading clinical laboratory is partnering with Silicon Valley-based CellMax Life to immediately introduce CellMax Life’s multi-biomarker precision oncology tests blood and saliva tests across Southeast Asia. CellMax Life’s Precision, Non-Invasive Cancer Testing Now Available throughout Southeast Asia through Asia Genomics.
0 kommentar(er)
